Published in Clin Pharmacol Ther on March 01, 1997
Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J (2000) 1.20
Nicotine treatment for ulcerative colitis. Br J Clin Pharmacol (1999) 0.87
Anti-inflammatory effects of the nicotinergic peptides SLURP-1 and SLURP-2 on human intestinal epithelial cells and immunocytes. Biomed Res Int (2014) 0.81
An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics. Br J Clin Pharmacol (1999) 0.79
Comparative study of enema retention and preference in ulcerative colitis. Postgrad Med J (2005) 0.75
Effect of general practitioners' advice against smoking. Br Med J (1979) 24.07
Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health (1987) 8.59
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
Absorption by non-smokers of carbon monoxide from room air polluted by tobacco smoke. Lancet (1973) 5.52
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther (2011) 5.44
Changes in cigarette price and consumption by men in Britain, 1946-71: a preliminary analysis. Br J Prev Soc Med (1973) 5.35
A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol (1990) 4.84
Expired air carbon monoxide: a simple breath test of tobacco smoke intake. Br Med J (1980) 4.82
Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br Med J (1980) 4.76
Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52
Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) (1982) 4.08
Cigarette dependence: II. Doctor's role in management. Br Med J (1971) 3.99
Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health (1984) 3.95
Improved gas chromatographic method and micro-extraction technique for the measurement of nicotine in biological fluids. J Pharm Pharmacol (1979) 3.72
The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther (2002) 3.71
Realistic goals for smoking and health. A case for safer smoking. Lancet (1974) 3.68
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet (2000) 3.68
Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. Br Med J (Clin Res Ed) (1983) 3.64
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology (2001) 3.60
Low-tar medium-nicotine cigarettes: a new approach to safer smoking. Br Med J (1976) 3.55
An oral preparation to release drugs in the human colon. Br J Clin Pharmacol (1982) 3.49
Incidence of Crohn's disease in Cardiff between 1934-1977. Gut (1979) 3.35
Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ (1989) 3.34
Smoking in Britain: strategy for future emancipation. Br J Addict Alcohol Other Drugs (1971) 3.06
Randomised controlled trial of nicotine chewing-gum. Br Med J (Clin Res Ed) (1982) 2.92
Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ (1993) 2.91
Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90
Double-blind trials. Br J Psychiatry (1990) 2.88
Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86
Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology (1969) 2.86
Passive smoking, salivary cotinine concentrations, and middle ear effusion in 7 year old children. BMJ (1989) 2.81
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis (2001) 2.80
Plasma nicotine levels after smoking cigarettes with high, medium, and low nicotine yields. Br Med J (1975) 2.80
Clinical use of nicotine chewing-gum. Br Med J (1980) 2.79
Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction (1995) 2.71
Cigarette smoking: natural history of a dependence disorder. Br J Med Psychol (1971) 2.71
Myelopoiesis in the zebrafish, Danio rerio. Blood (2001) 2.67
Natural history of patients with x-ray-negative dyspepsia in general practice. Br Med J (1972) 2.67
Comparison of effect on tobacco consumption and carbon monoxide absorption of changing to high and low nicotine cigarettes. Br Med J (1973) 2.65
Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Am J Public Health (1988) 2.63
Breakfast and dietary aspects of Crohn's disease. Br Med J (1978) 2.57
Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative population sample of non-smoking schoolchildren. Br Med J (Clin Res Ed) (1985) 2.51
Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. Gastroenterology (2001) 2.46
Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J (1999) 2.44
Assay of nicotine in biological materials: sources of contamination and their elimination. J Pharm Pharmacol (1980) 2.43
Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux. Br J Surg (2005) 2.42
Effect of nicotine chewing gum on smoking behaviour and as an aid to cigarette withdrawal. Br Med J (1976) 2.41
Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg (2003) 2.40
Cigarette smoking: a dependence on high-nicotine boli. Drug Metab Rev (1978) 2.36
Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect (2008) 2.35
Saliva cotinine as an indicator of cigarette smoking in adolescents. Br J Addict (1987) 2.33
Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1982) 2.32
Blood carboxyhaemoglobin, plasma thiocyanate, and cigarette consumption: implications for epidemiological studies in smokers. Br Med J (Clin Res Ed) (1982) 2.32
Plasma nicotine levels after cigarette smoking and chewing nicotine gum. Br Med J (1976) 2.31
Huntington's Chorea in South Wales. A genetic and epidemiological study. Clin Genet (1981) 2.31
DNA replication licensing and human cell proliferation. J Cell Sci (2001) 2.30
Carboxyhaemoglobin and plasma thiocyanate: complementary indicators of smoking behaviour? Thorax (1982) 2.30
The "Schaltenbrand experiment," Würzburg, 1940: scientific, historical, and ethical perspectives. Neurology (1994) 2.30
Rapid gas-liquid chromatographic determination of cotinine in biological fluids. Analyst (1980) 2.29
Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys. BMJ (2000) 2.28
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28
Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis. Aliment Pharmacol Ther (2015) 2.25
Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet (1986) 2.24
Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry (2001) 2.23
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22
Disodium cromoglycate in the treatment of chronic proctitis. Gut (1975) 2.21
Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine. Aliment Pharmacol Ther (2010) 2.20
What determines levels of passive smoking in children with asthma? Thorax (1997) 2.20
Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut (2009) 2.20
A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease. Aliment Pharmacol Ther (2014) 2.18
Determinants of passive smoking in children in Edinburgh, Scotland. Am J Public Health (1992) 2.17
Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey. J Natl Cancer Inst (2001) 2.16
Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness. Lancet (1999) 2.15
Balsalazide and azathiprine or 6-mercaptopurine: evidence for a potentially serious drug interaction. Gastroenterology (1999) 2.14
Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy. Postgrad Med J (2001) 2.14
Adjustment of smokers to dilution of tobacco smoke by ventilated cigarette holders. Clin Pharmacol Ther (1978) 2.09